Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High Systemic Immune Inflammation Index Is Associated With Low Skeletal Muscle Quantity in Resectable Pancreatic Ductal Adenocarcinoma.
Aziz MH, van Dongen JC, Saida L, Suker M, van Vugt JLA, van Putten Y, Sideras K, Groen JV, Mieog JSD, Lucassen CJ, Droop A, Mauff K, Shahbazi Feshtali S, Groot Koerkamp B, Mustafa DAM, van Eijck CJ. Aziz MH, et al. Among authors: van dongen jc. Front Oncol. 2022 Feb 28;12:827755. doi: 10.3389/fonc.2022.827755. eCollection 2022. Front Oncol. 2022. PMID: 35296013 Free PMC article.
C-reactive protein is superior to white blood cell count for early detection of complications after pancreatoduodenectomy: a retrospective multicenter cohort study.
van Dongen JC, Smits FJ, van Santvoort HC, Molenaar IQ, Busch OR, Besselink MG, Aziz MH, Groot Koerkamp B, van Eijck CHJ; Dutch Pancreatic Cancer Group. van Dongen JC, et al. Among authors: van santvoort hc, van eijck chj. HPB (Oxford). 2020 Oct;22(10):1504-1512. doi: 10.1016/j.hpb.2020.02.005. Epub 2020 Mar 11. HPB (Oxford). 2020. PMID: 32171648 Free article.
Surgical Complications in a Multicenter Randomized Trial Comparing Preoperative Chemoradiotherapy and Immediate Surgery in Patients With Resectable and Borderline Resectable Pancreatic Cancer (PREOPANC Trial).
van Dongen JC, Suker M, Versteijne E, Bonsing BA, Mieog JSD, de Vos-Geelen J, van der Harst E, Patijn GA, de Hingh IH, Festen S, Ten Tije AJ, Busch OR, Besselink MG, van Tienhoven G, Koerkamp BG, van Eijck CHJ; Dutch Pancreatic Cancer Group. van Dongen JC, et al. Ann Surg. 2022 May 1;275(5):979-984. doi: 10.1097/SLA.0000000000004313. Epub 2020 Nov 12. Ann Surg. 2022. PMID: 33201120 Clinical Trial.
The effect of preoperative chemotherapy and chemoradiotherapy on pancreatic fistula and other surgical complications after pancreatic resection: a systematic review and meta-analysis of comparative studies.
van Dongen JC, Wismans LV, Suurmeijer JA, Besselink MG, de Wilde RF, Groot Koerkamp B, van Eijck CHJ. van Dongen JC, et al. HPB (Oxford). 2021 Sep;23(9):1321-1331. doi: 10.1016/j.hpb.2021.04.027. Epub 2021 May 19. HPB (Oxford). 2021. PMID: 34099372 Free article. Review.
Age and prognosis in patients with pancreatic cancer: a population-based study.
van Dongen JC, van der Geest LGM, de Meijer VE, van Santvoort HC, de Vos-Geelen J, Besselink MG, Groot Koerkamp B, Wilmink JW, van Eijck CHJ; Dutch Pancreatic Cancer Group. van Dongen JC, et al. Acta Oncol. 2022 Mar;61(3):286-293. doi: 10.1080/0284186X.2021.2016949. Epub 2021 Dec 22. Acta Oncol. 2022. PMID: 34935577
Fistula Risk Score for Auditing Pancreatoduodenectomy: The Auditing-FRS.
van Dongen JC, van Dam JL, Besselink MG, Bonsing BA, Bosscha K, Busch OR, van Dam RM, Festen S, van der Harst E, de Hingh IH, Kazemier G, Liem MSL, de Meijer VE, Mieog JSD, Molenaar IQ, Patijn GA, van Santvoort HC, Wijsman JH, Stommel MWJ, Wit F, De Wilde RF, van Eijck CHJ, Groot Koerkamp B; Dutch Pancreatic Cancer Group. van Dongen JC, et al. Ann Surg. 2023 Aug 1;278(2):e272-e277. doi: 10.1097/SLA.0000000000005532. Epub 2022 Jul 15. Ann Surg. 2023. PMID: 35837978
The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial.
van Dongen JC, Versteijne E, Bonsing BA, Mieog JSD, de Hingh IHJT, Festen S, Patijn GA, van Dam R, van der Harst E, Wijsman JH, Bosscha K, van der Kolk M, de Meijer VE, Liem MSL, Busch OR, Besselink MGH, van Tienhoven G, Groot Koerkamp B, van Eijck CHJ, Suker M; Dutch Pancreatic Cancer Group. van Dongen JC, et al. Eur J Surg Oncol. 2023 Apr;49(4):811-817. doi: 10.1016/j.ejso.2022.12.011. Epub 2022 Dec 26. Eur J Surg Oncol. 2023. PMID: 36585300 Clinical Trial.
Impact of complications after resection of pancreatic cancer on disease recurrence and survival, and mediation effect of adjuvant chemotherapy: nationwide, observational cohort study.
Henry AC, van Dongen JC, van Goor IWJM, Smits FJ, Nagelhout A, Besselink MG, Busch OR, Bonsing BA, Bosscha K, van Dam RM, Festen S, Groot Koerkamp B, van der Harst E, de Hingh IH, van der Kolk M, Liem MSL, de Meijer VE, Patijn GA, Roos D, Schreinemakers JM, Wit F, Daamen LA, van Santvoort HC, Molenaar IQ, van Eijck CHJ. Henry AC, et al. Among authors: van dongen jc. BJS Open. 2023 Mar 7;7(2):zrac174. doi: 10.1093/bjsopen/zrac174. BJS Open. 2023. PMID: 36959099 Free PMC article.
Preoperative chemoradiotherapy but not chemotherapy is associated with reduced risk of postoperative pancreatic fistula after pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a nationwide analysis.
Wismans LV, Suurmeijer JA, van Dongen JC, Bonsing BA, Van Santvoort HC, Wilmink JW, van Tienhoven G, de Hingh IH, Lips DJ, van der Harst E, de Meijer VE, Patijn GA, Bosscha K, Stommel MW, Festen S, den Dulk M, Nuyttens JJ, Intven MPW, de Vos-Geelen J, Molenaar IQ, Busch OR, Koerkamp BG, Besselink MG, van Eijck CHJ; Dutch Pancreatic Cancer Group. Wismans LV, et al. Among authors: van dongen jc. Surgery. 2024 Jun;175(6):1580-1586. doi: 10.1016/j.surg.2024.01.029. Epub 2024 Mar 5. Surgery. 2024. PMID: 38448277 Free article.
13 results